Info/Guidance for Health Care Providers
Guidance and information for various health care settings and services from the N.C. Department of Health and Human Services.
Can't find what you're looking for? Search the CDC's COVID-19 website.
Important Update: COVID-19 Statewide Standing Orders Expire Dec. 31, 2024
The COVID-19 Statewide Standing Orders (SWSOs) authorized under North Carolina Session Law 2022-74, Sec. 9G.7.(a)-(e) (PDF) and extended under Session Law 2023-65, Sec. 9G.7 (PDF), will expire on Dec. 31, 2024. Read the memo (PDF).
General Guidance
Accessibility
- Accessibility Tips, Tricks and FAQs (Spanish)
- Advancing Equity through Language, Communication and Physical Access (Spanish)
- Accessibility at Drive-Thru Medical Sites
- Historically Marginalized Populations Engagement Toolkit
- Americans with Disabilities Act (ADA) and Section 504 Rehabilitation Act (RA) Protections during COVID-19
Long-Term Care Facilities
Regional Infection Prevention Teams
- RIPS Team Program Overview
- Comprehensive RIPS ICAR
- Environmental Rounds Tool - for use in small family care/group homes
Pregnancy and Child Health
- COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics
- CDC Pediatric Healthcare Providers Caring for Children
- Multisystem Inflammatory Syndrome in Children (MIS-C)
Testing
General Guidance
- Testing Info for Partners and Providers
- NC Division of Public Health COVID-19 Guidance
- Request Specimen Collection Supplies
- CDC - Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing
(Go to Long-Term Care Facilities for setting-specific testing guidance)
Reporting
Statewide Standing Orders for Testing
- Order for COVID-19 Diagnostic Testing (March 14, 2024)
- Order to Allow Pharmacists to Dispense Over the Counter At-Home COVID-19 Tests (Jan. 14, 2022)
Therapeutics
Statewide Standing Order Recissions for Therapeutics
- Intravenous Administration of Bebtelovimab Monoclonal Antibodies (Nov. 30, 2022)
- Intravenous Administration of Sotrovimab Monoclonal Antibodies (April 6, 2022)
- Subcutaneous Administration of Casirivimab/Imdevimab (REGEN-COV) Monoclonal Antibodies (Jan. 24, 2022)
- Intravenous Administration of Casirivimab/Imdevimab (REGEN-COV) Monoclonal Antibodies (Jan. 24, 2022)
- Intravenous Administration of Bamlanivimab/Etesevimab Monoclonal Antibodies (Jan. 24, 2022)
Vaccines
General Guidance
- Secretarial Order 8 (March 3, 2021) - Allows licensed dentists to administer COVID-19 vaccinations
- Coadministration of the COVID-19 Vaccine (Sept. 24, 2021)
- Learn About NCIR
Statewide Standing Orders for Vaccine Administration
Moderna Vaccines
- Moderna COVID-19 Vaccine for 6 Months-11 Years (Aug. 30, 2024)
- Moderna COVID-19 Vaccine for 12 Years and Older (Aug. 30, 2024)
Pfizer Vaccines
- Pfizer-BioNTech COVID-19 Vaccine for 6 Months-11 Years (Aug. 30, 2024)
- Pfizer-BioNTech COVID-19 Vaccine for 12 Years and Older (Aug. 30, 2024)
Novavax Vaccine
- Novavax COVID-19 Vaccine for 12 Years and Older (Sept. 13, 2024)